Viewing Study NCT06198517



Ignite Creation Date: 2024-05-06 @ 7:57 PM
Last Modification Date: 2024-10-26 @ 3:17 PM
Study NCT ID: NCT06198517
Status: RECRUITING
Last Update Posted: 2024-01-16
First Post: 2023-12-21

Brief Title: Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT
Sponsor: Wuhan Union Hospital China
Organization: Wuhan Union Hospital China

Study Overview

Official Title: Clinical Study of Moxibustion for the Prevention of Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study was a prospective multicenter randomized controlled clinical study planned to recruit 254 hematological patients with allogeneic hematopoietic stem cell transplantation allo-HSCT who were randomly divided into two groups according to gender type of transplantation and type of primary disease The control group was treated conventionally and the experimental group increased moxibustion of Zhongji Guanyuan and Qihai for 30 min qd starting on the first day after HSCT was performed until the 14th day after transplantation Urine routine was collected daily before cyclophosphamide administration until 14d and bloodurine BK virus JC virus and adenovirus were tested at four time points 1d 14 days appearance of hematuria symptom and remission of HC and urine routine was tested once every 7 days for all patients within three months and severity grading should be performed for patients with Hemorrhagic cystitis HC pain scores and the main TCM evidence profile aiming to evaluate the effectiveness of moxibustion in preventing HC in this group of patients
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None